{{Rsnum
|rsid=2903265
|Gene=ZFAND6
|Chromosome=15
|position=80121042
|Orientation=plus
|GMAF=0.365
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ZFAND6
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 8.9 | 38.4 | 52.7
| HCB | 29.2 | 46.0 | 24.8
| JPT | 38.1 | 50.4 | 11.5
| YRI | 10.9 | 51.0 | 38.1
| ASW | 15.8 | 52.6 | 31.6
| CHB | 29.2 | 46.0 | 24.8
| CHD | 31.2 | 45.9 | 22.9
| GIH | 10.9 | 44.6 | 44.6
| LWK | 23.6 | 46.4 | 30.0
| MEX | 3.4 | 24.1 | 72.4
| MKK | 21.2 | 48.7 | 30.1
| TSI | 9.8 | 39.2 | 51.0
| HapMapRevision=28
}}[[rs2903265]] has been reported in a large study to be associated with [[type-2 diabetes]].

The risk allele (oriented to the dbSNP entry) is (G); the odds ratio associated with heterozygotes is 1.18 (CI 0.93-1.49), and for homozygotes, 1.47 (CI 1.17-1.86). {{PMID|17554300|OA=1
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}